Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ABBOTT LABORATORIES

(ABT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Abbott Laboratories Names Patricia P. Gonzalez as Board of Directors

09/01/2021 | 07:11am EDT

On August 30, 2021, Patricia P. Gonzalez was named to the Abbott Laboratories’ (“Abbott”) Board of Directors.


ę S&P Capital IQ 2021
All news about ABBOTT LABORATORIES
10/15ABBOTT LABORATORIES : Recalls Two COVID-19 Lab Kits After False Results
MT
10/14Abbott Labs unit recalling two COVID-19 lab test kits - FDA
RE
10/14Abbott Labs unit recalling two COVID-19 test kits - FDA
RE
10/14ABBOTT LABORATORIES : Redburn Partners Starts Abbott Laboratories at Neutral
MT
10/14ABBOTT LABORATORIES : Ex-dividend day for
FA
10/11Health Care Stocks Sliding in Late Monday Trading
MT
10/11Health Care Stocks Drifting Monday as Biotechs Climb
MT
10/01ANALYST RECOMMENDATIONS : Acceleron Pharma, General Mills, Southwest Airlines, Home Depot,..
09/30ABBOTT : Commits to Reducing Malnutrition Globally with Launch of Abbott : Center for Maln..
PR
09/30Abbott Laboratories Launches Effort to Reduce Worldwide Malnutrition
DJ
More news
Analyst Recommendations on ABBOTT LABORATORIES
More recommendations
Financials (USD)
Sales 2021 39 971 M - -
Net income 2021 5 554 M - -
Net Debt 2021 8 589 M - -
P/E ratio 2021 35,9x
Yield 2021 1,45%
Capitalization 208 B 208 B -
EV / Sales 2021 5,43x
EV / Sales 2022 5,43x
Nbr of Employees 109 000
Free-Float 88,8%
Chart ABBOTT LABORATORIES
Duration : Period :
Abbott Laboratories Technical Analysis Chart | ABT | US0028241000 | MarketScreener
Technical analysis trends ABBOTT LABORATORIES
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 25
Last Close Price 117,49 $
Average target price 130,28 $
Spread / Average Target 10,9%
EPS Revisions
Managers and Directors
Robert B. Ford President, CEO, Chief Operating Officer & Director
Robert Emmett Funck Chief Financial Officer & Executive VP-Finance
Miles D. White Executive Chairman
Sabina Ewing Chief Investment Officer, VP-Business & Technology
Roxanne Schuh Austin Independent Director
Sector and Competitors
1st jan.Capi. (M$)
ABBOTT LABORATORIES7.31%208 288
MEDTRONIC PLC9.06%171 927
BECTON, DICKINSON AND COMPANY-3.62%69 259
HOYA CORPORATION20.71%55 655
DEXCOM, INC.47.27%52 677
SARTORIUS STEDIM BIOTECH60.65%50 025